OPIANT PHARMACEUTICALS, INC. insider trading activity
Understanding Insider Activity at OPIANT PHARMACEUTICALS, INC.
Welcome to our dedicated page for OPIANT PHARMACEUTICALS, INC. (Nasdaq: OPNT) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by OPIANT PHARMACEUTICALS, INC.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for OPIANT PHARMACEUTICALS, INC., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for OPNT| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| OPNT | 9:22:43 PM 1/31/2023 | CRYSTAL ROGER(Chief Executive Officer) sold 1358 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$27513 | Filing |
| OPNT | 9:21:37 PM 1/31/2023 | Ellison Mark Jason Heath(Chief Development Officer) sold 610 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$12358 | Filing |
| OPNT | 9:20:27 PM 1/31/2023 | Gorman Brian sold 444 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$8995 | Filing |
| OPNT | 9:19:24 PM 1/31/2023 | Skolnick Phil(Chief Scientific Officer) sold 480 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$9724 | Filing |
| OPNT | 9:17:29 PM 1/31/2023 | O'Toole David D(Chief Financial Officer) sold 541 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$10960 | Filing |
| OPNT | 10:16:08 PM 1/9/2023 | O'Toole David D(Chief Financial Officer) sold 415 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$8383 | Filing |
| OPNT | 10:13:58 PM 1/9/2023 | Ellison Mark Jason Heath(Chief Development Officer) sold 469 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$9473 | Filing |
| OPNT | 10:11:54 PM 1/9/2023 | Skolnick Phil(Chief Scientific Officer) sold 369 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$7453 | Filing |
| OPNT | 10:09:24 PM 1/9/2023 | CRYSTAL ROGER(Chief Executive Officer) sold 1183 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$23896 | Filing |
| OPNT | 10:07:25 PM 1/5/2023 | Ellison Mark Jason Heath(Chief Development Officer) sold 1806 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$36481 | Filing |
| OPNT | 10:03:45 PM 1/5/2023 | O'Toole David D(Chief Financial Officer) sold 1600 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$32320 | Filing |
| OPNT | 9:59:40 PM 1/5/2023 | Gorman Brian sold 1313 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$26522 | Filing |
| OPNT | 9:56:03 PM 1/5/2023 | Skolnick Phil(Chief Scientific Officer) sold 1421 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$28704 | Filing |
| OPNT | 9:52:01 PM 1/5/2023 | CRYSTAL ROGER(Chief Executive Officer) sold 5029 shares of OPIANT PHARMACEUTICALS, INC. (OPNT) for ~$101585 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 14 insider filings.
Register now to dive deeper and explore the full dataset.
Discover more companies
- OPTILEAF, INC. (OPLF)
- OPKO HEALTH, INC. (OPK)
- OFFICE PROPERTIES INCOME TRUST (OPINL)
- OFFICE PROPERTIES INCOME TRUST (OPI)
- OLD POINT FINANCIAL CORP (OPOF)
- RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (OPP)
- RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (OPP-PA)
- RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (OPP-PB)